World's Best Scientists 2026 revealed!
Peter F.A. Mulders

Peter F.A. Mulders

D-Index & Metrics

Medicine

D-Index
87
Citations
42382
World Ranking
13412
National Ranking
511

Overview

Peter F.A. Mulders is affiliated with Radboud University in the Netherlands and has a research focus primarily in the medical and biochemical sciences. Their scholarly output covers a range of topics including renal cell carcinoma treatment, prostate cancer treatment and research, and molecular biology techniques and applications. The scientific work also delves into radiomics and machine learning in medical imaging, as well as radiopharmaceutical chemistry and applications.

Their research is frequently published in venues such as European Urology Open Science, Tijdschrift voor Urologie, Prostate Cancer and Prostatic Diseases, Journal of Clinical Oncology, and World Journal of Urology. These journals reflect their engagement with urology, oncology, and clinical cancer research.

Recent papers by Peter F.A. Mulders include:

  • Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men (2021, Prostate Cancer and Prostatic Diseases)
  • Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology (2020, Prostate Cancer and Prostatic Diseases)
  • [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma (2022, Clinical Cancer Research)
  • Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model (2022, Pharmaceuticals)
  • Cytoreductive nephrectomy and exposure to sunitinib - a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial (2021, British Journal of Urology)

They regularly collaborate with several co-authors, including Inge M. van Oort, Egbert Oosterwijk, Stijn Muselaers, Bas Israël, and Hans de Jong. The frequency of collaboration with these researchers indicates a network within oncology and urology research fields.

Peter F.A. Mulders' research covers important subfields such as pulmonary and respiratory medicine, molecular biology, radiology, nuclear medicine and imaging, cancer research, and oncology. Main fields of study include medicine as well as biochemistry, genetics, and molecular biology.

Key research topics encompass:

  • Renal cell carcinoma treatment
  • Prostate cancer treatment and research
  • Renal and related cancers
  • Prostate cancer diagnosis and treatment
  • Radiomics and machine learning in medical imaging
  • Radiopharmaceutical chemistry and applications
  • Molecular biology techniques and applications

Best Publications

  • Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Howard I. Scher;Karim Fizazi;Fred Saad;Mary-Ellen Taplin

  • Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina

  • EAU Guidelines on Renal Cell Carcinoma: 2014 Update

    Borje Ljungberg;Karim Bensalah;Steven Canfield;Saeed Dabestani

  • A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

    Thorgeir E Thorgeirsson;Frank Geller;Patrick Sulem;Thorunn Rafnar

  • GuidelinesEAU Guidelines on Renal Cell Carcinoma: The 2010 Update

    Börje Ljungberg;Nigel C. Cowan;Damian C. Hanbury;Milan Hora

  • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Charles J. Ryan;Matthew R. Smith;Karim Fizazi;Fred Saad

  • Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

    Jean Jacques Patard;Emmanuelle Leray;Nathalie Rioux-Leclercq;Luca Cindolo

  • Resting-state functional connectivity in major depressive disorder: A review

    Peter C. Mulders;Philip F. van Eijndhoven;Aart H. Schene;Christian F. Beckmann

  • SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE

    Jean-Jacques Patard;Oleg Shvarts;John S. Lam;Allan J. Pantuck

  • Renal cell carcinoma guideline.

    Börje Ljungberg;Damian C. Hanbury;Marcus A. Kuczyk;Axel S. Merseburger

  • Multi-institutional validation of a new renal cancer-specific survival nomogram.

    Pierre I. Karakiewicz;Alberto Briganti;Felix K H Chun;Quoc Dien Trinh

  • Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

    Alexander Haese;Alexandre de la Taille;Hendrik van Poppel;Michael Marberger

  • Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy

    Lorenzo Marconi;Saeed Dabestani;Thomas B. Lam;Fabian Hofmann

  • Guidelines on Renal Cell Carcinoma

    Börje Ljungberg;D C Hanbury;M A Kuczyk;A S Merseburger

  • Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

    Jean Jacques Patard;Hyung L. Kim;John S. Lam;Frederick J. Dorey

  • An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

    Christopher Wood;Pramod Srivastava;Ronald Bukowski;Louis Lacombe

  • Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer ☆

    Gisele H.J.M. Leyten;Daphne Hessels;Sander A. Jannink;Frank P. Smit

  • Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: The surtime randomized clinical trial

    Axel Bex;Peter Mulders;Michael A.S. Jewett;John Wagstaff

  • Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.

    Tomasz M. Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

    J.-J. Patard;E. Leray;N. Rioux-Leclercq;L. Cindolo

Frequent Co-Authors

Jack A. Schalken
Jack A. Schalken Radboud University
Wim J.G. Oyen
Wim J.G. Oyen Humanitas University
Otto C. Boerman
Otto C. Boerman Radboud University
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Alexandre de la Taille
Alexandre de la Taille Université Paris Cité
Fred Saad
Fred Saad University of Montreal
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Arturo Molina
Arturo Molina Sutro Biopharma
Matthew R. Smith
Matthew R. Smith Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medical education, online degrees offer a flexible way to start or advance your healthcare career. From entry-level to advanced programs, many students are choosing online pathways for their affordability and convenience.

For those interested in healthcare administration, consider the cheapest medical billing and coding online courses. These programs provide quick entry into the medical field without years of schooling.

Nursing continues to be an in-demand profession. If you’re looking for accessible RN or BSN programs, look into affordable nursing programs online. These allow you to balance life and study while working toward licensure.

Ambitious nurses looking to specialize may pursue the cheapest online fnp programs. Family Nurse Practitioner (FNP) training leads to higher salaries and more independent roles.

For those pursuing leadership or academic careers, an online phd nursing can open doors to research, teaching, and executive opportunities within healthcare.

Best Scientists Citing Peter F.A. Mulders

Trending Scientists